v3.26.1
Consolidated Statements of Assets and Liabilities - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Assets    
Fair Value $ 15,344,201 [1],[2] $ 16,470,893 [3],[4]
Cash (restricted cash of $13,519 and $47,448, respectively) 416,109 558,703
Foreign cash (cost of $39,615 and $9,722, respectively) 39,291 9,839
Interest and dividend receivable 100,467 104,576
Prepaid expenses and other assets 93,301 15,508
Total Assets 16,018,541 17,186,365
Liabilities    
Debt (net of unamortized debt issuance costs of $95,244 and $93,186, respectively) 8,454,559 9,300,076
Management fee payable 60,695 63,145
Distribution payable 183,707 184,877
Incentive fee payable 32,411 38,899
Accrued expenses and other liabilities 122,851 189,517
Total Liabilities 8,864,541 9,789,086
Commitments and contingencies (Note 8)
Net Assets    
Common shares $0.01 par value, 1,000,000,000 shares authorized; 496,305,391 and 499,448,499 shares issued and outstanding, respectively 4,963 4,994
Additional paid-in-capital 7,477,075 7,512,234
Accumulated undistributed (overdistributed) earnings (328,038) (119,949)
Total Net Assets 7,154,000 7,397,279
Total Liabilities and Net Assets $ 16,018,541 $ 17,186,365
Net Asset Value Per Share (in usd per share) $ 14.41 $ 14.81
Affiliated entity    
Assets    
Receivable from a controlled affiliate $ 25,172 $ 26,846
Liabilities    
Payables to affiliates 10,318 12,572
Non-controlled, non-affiliated investments    
Assets    
Fair Value 12,850,691 13,995,055
Non-controlled, affiliated investments    
Assets    
Fair Value 150,003 114,192
Controlled, affiliated investments    
Assets    
Fair Value $ 2,343,507 $ 2,361,646
[1] Certain portfolio company investments are subject to contractual restrictions on sales. Refer to footnote 30 for additional information on the Company’s restricted securities.
[2] Unless otherwise indicated, the Company’s portfolio companies are pledged as collateral supporting the amounts outstanding under the Revolving Credit Facility, SPV Asset Facilities and CLOs. See “Note 5 — Debt.”
[3] Certain portfolio company investments are subject to contractual restrictions on sales. Refer to footnote 30 for additional information on the Company’s restricted securities.
[4] Unless otherwise indicated, the Company’s portfolio companies are pledged as collateral supporting the amounts outstanding under the Revolving Credit Facility, SPV Asset Facilities and CLOs. See “Note 5 — Debt.”